Empiric Antibiotics for Transarterial Embolization in Hepatocellular Carcinoma: Indicated?

Journal of Surgical Research

Volumn 151, Issue 1, 2009, Pages 121-124

  Shelgikar, Chinmaya S ^a   Loehle, Jennifer ^a   Scoggins, Charles R ^a   McMasters, Kelly M ^a   Martin II, Robert C G ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotics; embolization; liver tumors

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; CISPLATIN; DOXORUBICIN; METRONIDAZOLE; MITOMYCIN C; YTTRIUM 90;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; CHEMOEMBOLIZATION; CHOLANGITIS; CONTROLLED STUDY; FEMALE; HUMAN; INFECTIOUS COMPLICATION; LENGTH OF STAY; LIVER ABSCESS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; TREATMENT INDICATION;

AGED; ANTI-BACTERIAL AGENTS; CARCINOMA, HEPATOCELLULAR; CHOLANGITIS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER ABSCESS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; MULTIVARIATE ANALYSIS; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEPSIS;

EID: 57149106337     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.02.039     Document Type: Article

References (10)

1. Wong J.B., McQuillan G.M., McHutchison J.G., et al. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 90 (2000) 1562
2. Befeler A.S. Chemoembolization and bland embolization: A critical appraisal. Clin Liver Dis 9 (2005) 287
3. Yamakado K., Nakatsuka A., Ohmori S., et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: Treatment response based on tumor size and morphology. J Vasc Interv Radiol 13 (2002) 1225
4. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37 (2003) 429
5. Bruix J., Llovet J.M., Castells A., et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution [see comments]. Hepatology 27 (1998) 1578
6. Castells A., Bruix J., Ayuso C., et al. Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol 22 (1995) 410
7. Brown D.B., Geschwind J.F., Soulen M.C., et al. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 17 (2006) 217
8. Ramsey D.E., Kernagis L.Y., Soulen M.C., et al. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13 (2002) S211
9. Brown D.B., Cardella J.F., Sacks D., et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 17 (2006) 225
10. Geschwind J.F., Kaushik S., Ramsey D.E., et al. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13 (2002) 1163